Bank of America
ACIU icon

Bank of America’s AC Immune ACIU Stock Holding History

Bank of America’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48K Sell
17,437
-4,034
-19% -$12.5K ﹤0.01% 5606
2025
Q4 		$67.4K Buy
21,471
+15,555
+263% +$49.1K ﹤0.01% 5742
2025
Q3 		$17.1K Buy
5,916
+343
+6% +$775 ﹤0.01% 7103
2025
Q2 		$11.3K Buy
5,573
+3,062
+122% +$5.33K ﹤0.01% 7170
2025
Q1 		$4.7K Sell
2,511
-377
-13% -$950 ﹤0.01% 7236
2024
Q4 		$7.8K Sell
2,888
-1,091
-27% -$3.41K ﹤0.01% 7026
2024
Q3 		$15K Buy
3,979
+1,087
+38% +$3.79K ﹤0.01% 6803
2024
Q2 		$11.5K Sell
2,892
-22
-0.8% -$73 ﹤0.01% 6866
2024
Q1 		$8.63K Buy
2,914
+2,656
+1,029% +$9.52K ﹤0.01% 6910
2023
Q4 		$1.29K Buy
+258
New +$829 ﹤0.01% 7169
2023
Q1 		– Sell
-10
Closed -$20 – 7756
2022
Q4 		$20 Sell
10
-410
-98% -$1.06K ﹤0.01% 7980
2022
Q3 		$2K Sell
420
-461
-52% -$1.45K ﹤0.01% 7547
2022
Q2 		$3K Sell
881
-2,873
-77% -$9.83K ﹤0.01% 7696
2022
Q1 		$15K Buy
3,754
+1,019
+37% +$4.41K ﹤0.01% 7619
2021
Q4 		$13K Sell
2,735
-7,143
-72% -$41.5K ﹤0.01% 7635
2021
Q3 		$66K Buy
9,878
+5,631
+133% +$40.3K ﹤0.01% 6916
2021
Q2 		$34K Buy
4,247
+3,613
+570% +$25K ﹤0.01% 6975
2021
Q1 		$4K Buy
+634
New +$4.53K ﹤0.01% 7143
2020
Q4 		– Sell
-67,065
Closed -$327K – 7062
2020
Q3 		$327K Buy
+67,065
New +$481K ﹤0.01% 5004
2020
Q2 		– Sell
-750
Closed -$5K – 6796
2020
Q1 		$5K Sell
750
-437
-37% -$3.42K ﹤0.01% 6490
2019
Q4 		$10K Buy
1,187
+437
+58% +$2.91K ﹤0.01% 6641
2019
Q3 		$4K Sell
750
-3,988
-84% -$21.4K ﹤0.01% 6873
2019
Q2 		$26K Buy
4,738
+4,729
+52,544% +$24.1K ﹤0.01% 6506
2019
Q1 		$0 Sell
9
-3,131
-100% -$19.9K ﹤0.01% 7058
2018
Q4 		$30K Buy
+3,140
New +$29.6K ﹤0.01% 6376

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Bank of America's ACIU Position: Q1 2026 in Review

Bank of America reduced its AC Immune (ACIU) stake by 19% in Q1 2026, selling an estimated $12.5K and leaving 17,437 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #5606.

Bank of America first reported a position in ACIU in Q4 2018 and has held it in 25 quarters since. The position peaked at $327K in Q3 2020. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

  • Bank of America held 17,437 shares of AC Immune worth $48K as of Q1 2026.
  • Bank of America sold 4,034 AC Immune shares in Q1 2026, an estimated $12.5K.
  • AC Immune made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5606 holding.
  • Bank of America first reported a position in AC Immune in Q4 2018 and has held it in 25 quarters since.
  • Bank of America's AC Immune position peaked at $327K in Q3 2020.
  • 46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.